Abstract
Objective
Women with gestational diabetes mellitus (GDM) are at risk to develop Type 2 diabetes mellitus (DM2). The aim of this study was to compare the effect of three international diagnostic criteria on the prevalence of GDM with its implications for prevention of DM2 in the population.
Materials and methods
One thousand one hundred and seventy-two pregnant women, who underwent the 75-g oral glucose tolerance test for routine, antenatal GDM screening, were classified using the criteria of the American Diabetes Association (ADA), the World Health Organization (WHO) and Australasian Diabetes in Pregnancy Society (ADIPS). The population-attributable risk, (PAR) was used to estimate the proportion of women with DM2 in the community, who may have been identified much in advance for intervention, by a GDM pregnancy.
Results
Using the ADA, WHO and ADPIS criteria, respectively: (a) the prevalence of GDM was 166 (14.2%), 242 (20.6%) and 271 (23.1%) (p < 0.0001); (b) The PAR (95% CI) was 42% (31–52%); 51% (39–62%) and 54% (42–64%). Overall, by all three criteria, 132 (11.3%) women had GDM while 859 (73.3%) were without GDM; the remaining 181 (15.4%) women had classification differences between them.
Conclusion
The universal acceptance and the ability of the WHO criteria to detect over half the women with DM2 earlier during pregnancy, makes it ideally suited to identify women with GDM.
Similar content being viewed by others
References
Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053
Cheung NW, Byth K (2003) Population health significance of gestational diabetes. Diabetes Care 26:2005–2009
Greene MF (1997) Screening for gestational diabetes mellitus. N Engl J Med 337:1625–1626
Kim C, Newton KM, Knopp RH (2002) Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25:1862–1868
Ben-Haroush A, Yogev Y, Hod M (2004) Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes. Diabet Med 21:103–113
Diabetes Prevention Program Research Group (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403
Buchanan TA, Xiang AH, Peters RK, Kjos SL, Marroquin A, Goico J, et al (2002) Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. Diabetes 51:2796–2803
International Diabetes Federation (2003) Diabetes e-Atlas, 2nd edn. International Diabetes Federation, Brussels
Agarwal MM, Hughes PF, Punnose J, Ezimokhai M (2000) Fasting plasma glucose as a screening test for gestational diabetes in a multi-ethnic, high-risk population. Diabet Med 17:720–726
Gestational Diabetes Mellitus (2004) Position statement American Diabetes Association. Diabetes Care 27(Suppl. 1):S88–S90
World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus. Report of a WHO Consultation. WHO, Geneva
The Australasian Diabetes in Pregnancy Society (1998) Gestational diabetes mellitus guidelines. Med J Aust. 169:93–97
Agarwal MM, Dhatt GS, Punnose J, Koster G (2005) Gestational diabetes: dilemma caused by multiple international diagnostic criteria. Diabet Med 22:1731–1736
Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M (2002) Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 48:436–472
Brody SC, Harris R, Lohr K (2003) Screening for gestational diabetes: a summary of the evidence for the U.S. Preventive Services Task Force. Obstet Gynecol 101:380–392
Daniells S, Grenyer BF, Davis WS, Coleman KJ, Burgess JA, Moses RG (2003) Gestational diabetes mellitus: is a diagnosis associated with an increase in maternal anxiety and stress in the short and intermediate term? Diabetes Care 26:385–389
Schmidt MI, Duncan BB, Reichelt AJ, Branchtein L, Matos MC, Costa e Forti A, et al (2001) Brazilian Gestational Diabetes Study Group. Gestational diabetes mellitus diagnosed with a 2-h 75-g oral glucose tolerance test and adverse pregnancy outcomes. Diabetes Care 24:1151–1155
Fraser R (2006) Gestational diabetes: after the ACHOIS trial. Diabet Med 23(Suppl 1):8–11
Watson D, Rowan J, Neale L, Battin MR (2003). Admissions to neonatal intensive care unit following pregnancies complicated by gestational or type 2 diabetes. Aust N Z J Obstet Gynaecol 43:429–432
HAPO Study Cooperative Research Group (2002) Special communication: the hyperglycemia and adverse pregnancy outcome (HAPO) study. Int J Gynecol Obstet 78:69–77
Acknowledgement
We would like to thank Ms. A. Matera for help with data collection and data entry.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Agarwal, M.M., Dhatt, G.S., Zayed, R. et al. Gestational diabetes: relevance of diagnostic criteria and preventive strategies for Type 2 diabetes mellitus. Arch Gynecol Obstet 276, 237–243 (2007). https://doi.org/10.1007/s00404-007-0334-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-007-0334-4